Ir para o conteúdo principal

biote (NASDAQ: BTMD) — Perfil da empresa, notícias e dados financeiros

Logo de biote
BTMD biote
biote  primary media
Perfil da empresa

biote

Biote (NASDAQ:BTMD) specializes in hormone optimization and personalized healthcare solutions, focusing on addressing hormonal imbalances through bio-identical hormone replacement therapy (BHRT). With a patient-centered approach, Biote aims to enhance the quality of life for individuals by offering tailored treatment plans that address a wide range of hormonal issues. Their projects extend into research and development of new protocols for hormone optimization, aiming to set new standards in personalized medicine. Biote's objectives are to expand its market reach, continuously improve patient outcomes through innovative therapies, and contribute to the broader understanding of hormone-related health conditions.

Resumo

Public USParticipação acionária
2012Ano de fundação
194Funcionários
Irving, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
Irving, US

Produtos e/ou serviços de biote

  • Hormone optimization therapies, focusing on balancing hormones to improve patient health and wellbeing.
  • Bioidentical hormone replacement therapy (BHRT) pellets, a natural approach to addressing hormone imbalances.
  • Personalized hormone optimization plans, tailored to individual patient needs for comprehensive healthcare.
  • Nutraceuticals line, offering supplements to support hormone health and overall wellness.
  • Educational resources for practitioners, enhancing understanding of hormone optimization and BHRT.
  • Partnership programs with healthcare providers, expanding access to hormone optimization treatments.

equipe executiva do biote

  • Marc D. BeerExecutive Chairman
  • Robert C. PetersonInterim CEO, CFO & Chief Business Officer
  • John J. OlsenChief Information Officer
  • Dan MonicoGeneral Counsel
  • Richard Kevin KeyChief Digital Officer
  • Jade BeutlerHead of Nutraceuticals
  • Cory RiceChief Clinical Advisor & Member of Medical Advisory Board
  • Joey LopesSVP of Strategy & Commercial Operations
  • Komal BajajChief Medical Officer

Principais indicadores financeiros

Resultados divulgados pela biote , em USD.

Cap. de mercado
40 mi
Receita (TTM)
183,5 mi
P/L
8.4
LPA (diluído, TTM)
0.1
Dividend yield
—
Margem de lucro
3.2%
Receita e lucro anuais da biote
Fim do ano fiscalReceitaResultado operacionalLucro líquido
192,2 mi35,6 mi27 mi
197,2 mi31,6 mi3,2 mi
185,4 mi28,7 mi3,3 mi
165 mi-60,7 mi-969 mil